roll_call_votes: 112, senate, 2, 105
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| congress | chamber | session | roll_call_number | date | question | vote_type | description | result | bill_id | legislation_type | legislation_number | yea_count | nay_count | present_count | not_voting_count | source_url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 | senate | 2 | 105 | 2012-05-24 | On the Amendment S.Amdt. 2111 to S. 3187 (No short title on file) | Bingaman Amdt. No. 2111 -- To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market. | Amendment Rejected | 28 | 67 | 0 | 5 | https://www.senate.gov/legislative/LIS/roll_call_votes/vote1122/vote_112_2_00105.xml |